Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6695208 | 0.88 | KDM4E (0.35) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6698877 | 0.84 | KDM4E (0.35) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6697360 | 0.84 | KDM4E (0.35) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6701075 | 0.79 | KDM4E (0.36) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6750638 | 0.78 | KDM4E (0.36) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6697304 | 0.77 | KDM4E (0.36) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6697436 | 0.77 | KDM4E (0.36) | KDM4ETSHRKMT2AMEN1ALDH1A1 | |
| SCHEMBL6063254 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1 | |
| SCHEMBL6062724 | 0.74 | KDM4E (0.35) | KDM4EALDH1A1 | |
| SCHEMBL6699800 | 0.73 | KDM4E (0.37) | KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6777570-B2 | Process for producing norbornene derivative having organosilyl group | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040063982-A1 | Process for producing norbornene derivative having organosilyl group | MITSUBISHI CHEMICAL CORPORATION (JP) | 2004-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040063982-A1 | Process for producing norbornene derivative having organosilyl group | GRIA2, GRM2, GRM8 | KDM4E 2658/4885TSHR 1793/4885KMT2A 598/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.